Recombinant Activated Factor VII for Treatment of Enoxaparin-Induced Bleeding
- 1 June 2004
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (6) , 827
- https://doi.org/10.1016/s0025-6196(11)62639-6
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparinJournal of Thrombosis and Haemostasis, 2003
- Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirinAnnals of Hematology, 2003
- Acute subdural haematomas and enoxaparinJournal of Clinical Neuroscience, 2002
- On The Mechanism Of Inhibition Of Factor Viia By Synthetic Pentasaccharide, Low‐Molecular‐Weight Heparins And Unfractionated HeparinBritish Journal of Haematology, 2000
- Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- DETERMINATION OF THE KINETIC CONSTANTS OF TISSUE FACTOR/FACTOR VII/FACTOR VIIA AND ANTITHROMBIN/HEPARIN USING SURFACE PLASMON RESONANCEThrombosis Research, 1997